| Breakdown | Dec 2025 | Mar 2025 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 195.10M | 236.35M | 196.65M | 165.44M | 73.32M |
| Gross Profit | 75.65M | 91.73M | 99.00M | 93.15M | 24.89M |
| EBITDA | 133.25M | 168.54M | 158.84M | 134.61M | 63.64M |
| Net Income | 28.90M | 50.22M | 65.18M | 60.77M | 24.79M |
Balance Sheet | |||||
| Total Assets | 578.13M | 552.46M | 493.77M | 350.33M | 264.99M |
| Cash, Cash Equivalents and Short-Term Investments | 69.31M | 19.71M | 82.19M | 54.20M | 23.49M |
| Total Debt | 215.58M | 176.73M | 161.32M | 109.89M | 117.39M |
| Total Liabilities | 357.75M | 315.00M | 306.28M | 217.96M | 184.92M |
| Stockholders Equity | 211.26M | 231.18M | 180.37M | 128.96M | 72.72M |
Cash Flow | |||||
| Free Cash Flow | 22.02M | -41.65M | -59.48M | 53.78M | -1.01M |
| Operating Cash Flow | 121.98M | 143.64M | 139.26M | 142.73M | 51.82M |
| Investing Cash Flow | -112.94M | -181.63M | -149.37M | -72.16M | -29.35M |
| Financing Cash Flow | 32.27M | -21.45M | 39.56M | -34.73M | -19.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €467.06M | 8.13 | 12.38% | 4.20% | -17.43% | -41.52% | |
70 Outperform | €149.04M | 7.32 | 10.65% | 0.78% | -33.05% | 20.61% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
58 Neutral | €171.26M | 7.18 | 27.04% | 2.25% | -10.54% | 311.83% |